Computational investigation of novel farnesyltransferase inhibitors using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking and molecular dynamics simulation studies: A new insight into cancer treatment-Reference-Cited by-同舟云学术

Computational investigation of novel farnesyltransferase inhibitors using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking and molecular dynamics simulation studies: A new insight into cancer treatment

Published:2021-10 Issue: Volume:1241 Page:130667
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Safavi Arman,Ghodousi Elaheh Sadat,Ghavamizadeh Mehdi,Sabaghan Mohamad,Azadbakht Omid,veisi Ali,Babaei Hossein,Nazeri Zahra,Darabi Mehrnaz Karimi,Zarezade Vahid^ORCID

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference80 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Targeting metabolic reprogramming in KRAS-driven cancers;Kawada;Int. J. Clin. Oncol.,2017

3. ADAM17: an emerging therapeutic target for lung cancer;Saad;Cancers,2019

4. Recent advances of small molecule focal adhesion kinase (FAK) inhibitors as promising anticancer therapeutics;Lv;Curr. Med. Chem.,2021

5. Overview of PCTK3/CDK18: a cyclin-dependent kinase involved in specific functions in post-mitotic cells;Pepino;Curr. Med. Chem.,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic targets of stevioside in management of type 2 diabetes by network pharmacology and in-silico approach;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-08

2. 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors: From Molecular Design to Synthesis;Journal of Agricultural and Food Chemistry;2024-07-24

3. Thioxanthone-based ionic liquid as photocatalyst for a tandem cyclization reaction to synthesize pyrroloquinolinones;Applied Catalysis B: Environment and Energy;2024-07

4. Development of erythrina-based PARP-1/FTase dual-target inhibitors against lung cancer epithelial-mesenchymal transition (EMT) in vivo and in vitro;Bioorganic Chemistry;2024-07

5. Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights;Molecular Diversity;2024-06-04